No se han encontrado coincidencias con Morote, Juan,, pero utilizando en su lugar Morote Juan ...
Depósito Digital de Documentos de la UAB Encontrados 88 registros  1 - 10siguientefinal  ir al registro: La búsqueda tardó 0.01 segundos. 
1.
9 p, 440.0 KB Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and Prostate Cancer Detection / Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Picola, Natàlia (Hospital Universitari de Bellvitge) ; Muñoz-Rodríguez, Jesús (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Paesano, Nahuel (Clínica Creu Blanca) ; Ruiz-Plazas, Xavier (Hospital Universitari de Tarragona Joan XXIII) ; Muñoz-Rivero, Marta V. (Hospital Universitari Arnau de Vilanova) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Manuel, Gemma García-de (Hospital Universitari de Girona Doctor Josep Trueta) ; Miró, Berta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona)
Concerns exist regarding the effects of 5-alpha reductase inhibitors (5-ARIs) on multipa-rametric magnetic resonance imaging (mpMRI) and clinically significant prostate cancer (csPCa) detection. Our objective is to analyze the effect of 5-ARI on the prostate imaging-reporting and data system (PI-RADS) distribution and csPCa and insignificant PCa (iPCa) detection. [...]
2024 - 10.3390/biom14020193
Biomolecules, Vol. 14 (february 2024)  
2.
9 p, 213.6 KB Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations / Bancroft, E.K. (Institute of Cancer Research) ; Saya, S. (Institute of Cancer Research) ; Page, E.C. (Institute of Cancer Research) ; Myhill, K. (Institute of Cancer Research) ; Thomas, S. (Institute of Cancer Research) ; Pope, J. (Institute of Cancer Research) ; Chamberlain, A. (Institute of Cancer Research) ; Hart, R. (Birmingham Women's Hospital) ; Glover, W. (Birmingham Women's Hospital) ; Cook, J. (Sheffield Children's Hospital (Sheffield, Regne Unit)) ; Rosario, D.J. (Royal Hallamshire Hospital) ; Helfand, B.T. (NorthShore University HealthSystem) ; Hutten Selkirk, C. (NorthShore University HealthSystem) ; Davidson, R. (Queen Elizabeth University Hospital) ; Longmuir, M. (Queen Elizabeth University Hospital) ; Eccles, D.M. (University of Southampton) ; Gadea, Neus (Hospital Universitari Vall d'Hebron) ; Brewer, Carole (Royal Devon and Exeter Hospital) ; Barwell, Julian (University Hospitals Leicester) ; Salinas, Monica (Hospital Universitari de Bellvitge) ; Greenhalgh, L. (Liverpool Women's Hospital) ; Tischkowitz, M. (University of Cambridge) ; Henderson, A. (Newcastle upon Tyne Hospitals) ; Evans, D.G. (Central Manchester University Hospitals NHS Foundation Trust) ; Buys, S.S. (University of Utah Health) ; Eeles, R.A. (Institute of Cancer Research) ; Aaronson, Neil K (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Capellá, G. (Gabriel) (Hospital Universitari de Bellvitge) ; Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Mora Brugués, Josefina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Esquena, Salvador (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Balmaña Gelpí, Judith (Hospital Universitari Vall d'Hebron) ; Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
To report the baseline results of a longitudinal psychosocial study that forms part of the IMPACT study, a multi-national investigation of targeted prostate cancer (PCa) screening among men with a known pathogenic germline mutation in the BRCA1 or BRCA2 genes. [...]
2019 - 10.1111/bju.14412
BJU International, Vol. 123 Núm. 2 (february 2019) , p. 284-292  
3.
12 p, 597.5 KB A Diagnostic Accuracy Study of Targeted and Systematic Biopsies to Detect Clinically Significant Prostate Cancer, including a Model for the Partial Omission of Systematic Biopsies / Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Picola, Natàlia (Hospital Universitari de Bellvitge) ; Muñoz-Rodríguez, Jesús (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Paesano, Nahuel (Clínica Creu Blanca (Barcelona, Catalunya)) ; Ruiz-Plazas, Xavier (Hospital Universitari Joan XXIII de Tarragona) ; Muñoz-Rivero, Marta V. (Hospital Universitari Arnau de Vilanova) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; García-de Manuel, Gemma (Hospital Universitari de Girona Doctor Josep Trueta) ; Aisian, Ignacio (Hospital Clínic i Provincial de Barcelona) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Abascal, Jose Maria (Universitat Pompeu Fabra)
The primary objective of this study was to analyse the current accuracy of targeted and systematic prostate biopsies in detecting csPCa. A secondary objective was to determine whether there are factors predicting the finding of csPCa in targeted biopsies and, if so, to explore the utility of a predictive model for csPCa detection only in targeted biopsies. [...]
2023 - 10.3390/cancers15184543
Cancers, Vol. 15 (september 2023)  
4.
22 p, 3.7 MB Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Regis, Lucas (Hospital Universitari Vall d'Hebron) ; Mast, Richard (Hospital Universitari Vall d'Hebron) ; de Torres, Inés M. (Hospital Universitari Vall d'Hebron) ; Semidey, María E. (Hospital Universitari Vall d'Hebron) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Fàbrega-Santamaria, Anna (Hospital Universitari Vall d'Hebron) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Magnetic resonance imaging (MRI)-associated prostate-specific antigen density (mPSAD) and MRI predictive models have been proposed for improving the selection of candidates for prostate biopsy among men with suspected prostate cancer (PCa). [...]
2022 - 10.3390/cancers14102374
Cancers, Vol. 14 (may 2022)  
5.
18 p, 1.7 MB Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer : A Systematic Review / Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Regis, Lucas (Hospital Universitari Vall d'Hebron) ; Cuadras, Mercè (Hospital Universitari Vall d'Hebron) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Magnetic resonance imaging (MRI) has allowed the early detection of PCa to evolve towards clinically significant PCa (csPCa), decreasing unnecessary prostate biopsies and overdetection of insignificant tumours. [...]
2022 - 10.3390/cancers14194747
Cancers, Vol. 14 (september 2022)  
6.
22 p, 4.7 MB Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples / Olivan, M (Hospital Universitari Vall d'Hebron) ; García, Marta (Institut de Recerca Sant Joan de Déu) ; Suárez, Leticia (Hospital Universitari Vall d'Hebron) ; Guiu, Marc (Institut de Recerca Biomèdica) ; Gros, Laura (Hospital Universitari Vall d'Hebron) ; Méndez Fernández, Olga (Hospital Universitari Vall d'Hebron) ; Rigau, Marina (Hospital Universitari de Bellvitge) ; Reventós, Jaume (Hospital Universitari de Bellvitge) ; Segura, Miguel F. (Hospital Universitari Vall d'Hebron) ; de Torres, Inés (Hospital Universitari Vall d'Hebron) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; de la Cruz, Xavier (Hospital Universitari Vall d'Hebron) ; Gomis, Roger R. (Hospital Universitari de Bellvitge) ; Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Rodríguez-Barrueco, Ruth (Hospital Universitari de Bellvitge) ; Santamaría, Anna (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Prostate cancer (PCa) is the most prevalent cancer in males worldwide, and it was the fifth leading cause of cancer mortality in this group in 2020. Near 70% of advanced-stage PCa patients will undergo bone metastasis, suffering pathological complications that severely affect patients' quality of life and probably progress in most cases to lethal PCa. [...]
2021 - 10.3390/cancers13246202
Cancers, Vol. 13 (december 2021)  
7.
14 p, 2.2 MB A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Regis, Lucas (Hospital Universitari Vall d'Hebron) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Mendez, Olga (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Early detection of PCa (PCa) has evolved towards clinically significant PCa (csPCa) after the spread of pre-biopsy multiparametric magnetic resonance imaging (mpMRI). However, PCa suspicion remains based on prostate-specific antigen (PSA) elevation and/or abnormal digital rectal examination (DRE). [...]
2022 - 10.3390/cancers14205100
Cancers, Vol. 14 (october 2022)  
8.
9 p, 1.7 MB Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Méndez Fernández, Olga (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M. (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The Barcelona magnetic resonance imaging (MRI)-based risk calculator (BCN MRI-RC) exhibited, in the analysed population, better behaviour than the Rotterdam-MRI risk calculator to improve candidate selection for prostate biopsy for the early detection of clinically significant prostate cancer. [...]
2023 - 10.1016/j.euros.2023.03.013
European Urology Open Science, Vol. 53 (may 2023) , p. 46-54  
9.
10 p, 1013.3 KB Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice : ANALUTS study / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Gómez-Caamaño, Antonio (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ; de Celis, Raúl Poza (Hospital Txagorritxu HUA) ; Gómez-Veiga, Francisco (Complejo Hospitalario Universitario de A Coruña) ; Ciria, Juan P. (Hospital de Donostia (Sant Sebastià, País Basc)) ; Calleja, Jesús (Hospital Clínico Universitario Valladolid) ; Extramiana, Javier (Hospital Txagorritxu HUA) ; Pérez-Sampietro, Maria (Ipsen Pharma) ; Perrot, Valerie (Ipsen Pharma) ; Angulo, Javier C. (Universidad Europea de Madrid) ; Universitat Autònoma de Barcelona
To estimate the prevalence of lower urinary tract symptoms (LUTS) in patients with prostate cancer scheduled to receive LHRH analogs, and to assess the effectiveness of LHRH analogs on LUTS in patients presenting moderate/severe symptoms. [...]
2022 - 10.1002/nau.25031
Neurourology and Urodynamics, Vol. 41 (september 2022) , p. 1824-1833  
10.
3 p, 385.5 KB A risk-organised model for clinically significant prostate cancer early detection / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Mendez, Olga (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M. (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
2023 - 10.1002/bco2.230
BJUI Compass, Vol. 4 (march 2023) , p. 420-422  

Depósito Digital de Documentos de la UAB : Encontrados 88 registros   1 - 10siguientefinal  ir al registro:
Vea también: autores con nombres similares
1 Morote, J.
1 Morote, Joan
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.